Analysts expect Orchestra BioMed Holdings, Inc. to report revenue of 131,486.72 for Q3 26, against a range of 127,054.30 to 135,919.14. The most recent reported quarter, Q2 26, came in at 88,000.00, a 34.5% miss against the 134,251.41 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 987,000.00 | 253,000.00 | 868,000.00 | 836,000.00 | 861,000.00 | 30.92 M | 110,000.00 | 88,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 764,124.30 | 939,160.80 | 591,191.83 | 888,906.59 | 826,391.41 | 946,002.10 | 893,235.52 | 143,407.22 | 135,919.14 | 135,676.34 | 99,654.87 | 112,222.34 | 129,805.81 | 532,637.06 | 2.09 M | 1.82 M | ||||||||||
| Low Estimate | 697,960.58 | 790,394.80 | 488,788.13 | 747,742.35 | 720,109.67 | 787,715.42 | 821,196.78 | 125,095.60 | 127,054.30 | 113,718.62 | 83,175.13 | 104,243.42 | 118,292.09 | 458,797.04 | 1.76 M | 1.55 M | ||||||||||
| Consensus Estimate | 731,042.44 | 864,777.80 | 539,989.98 | 818,324.47 | 773,250.54 | 866,858.76 | 857,216.15 | 134,251.41 | 131,486.72 | 124,697.48 | 91,415.00 | 108,232.88 | 124,048.95 | 495,717.05 | 1.93 M | 1.68 M |
Analysts expect Orchestra BioMed Holdings, Inc. to report earnings per share of -0.39 for Q3 26, against a range of -0.42 to -0.36. The most recent reported quarter, Q2 26, came in at -0.38, a 7.3% beat against the -0.41 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.41 | -0.42 | -0.49 | -0.50 | -0.40 | 0.12 | -0.33 | -0.38 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.43 | -0.44 | -0.43 | -0.49 | -0.39 | -0.36 | -0.40 | -0.38 | -0.36 | -0.35 | -0.38 | -0.34 | -0.33 | -0.32 | -0.31 | -0.23 | ||||||||||
| Low Estimate | -0.45 | -0.48 | -0.49 | -0.55 | -0.45 | -0.44 | -0.48 | -0.44 | -0.42 | -0.41 | -0.42 | -0.36 | -0.39 | -0.38 | -0.35 | -0.27 | ||||||||||
| Consensus Estimate | -0.44 | -0.46 | -0.46 | -0.52 | -0.42 | -0.40 | -0.44 | -0.41 | -0.39 | -0.38 | -0.40 | -0.35 | -0.36 | -0.35 | -0.33 | -0.25 |
Pull Wall Street consensus for Orchestra BioMed Holdings, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=OBIO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "OBIO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=OBIO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();